Literature DB >> 17909622

Role for HLA in susceptibility to infectious mononucleosis.

Paul J Farrell1.   

Abstract

Factors involved in determining whether infectious mononucleosis occurs after primary EBV infection may include age, dose of virus received, and various genetic markers. A study by McAulay and colleagues reported in this issue of the JCI shows that the presence of certain HLA class I alleles correlates with the incidence and severity of infectious mononucleosis. These same HLA alleles are also risk factors for EBV-associated Hodgkin lymphoma (HL), supporting recent epidemiology that indicates that a history of infectious mononucleosis predisposes to HL. Recent studies suggest that an EBV vaccine might help to prevent infectious mononucleosis, and further development of this should now be considered.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17909622      PMCID: PMC1994638          DOI: 10.1172/JCI33563

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  19 in total

Review 1.  Persistence of the Epstein-Barr virus and the origins of associated lymphomas.

Authors:  David A Thorley-Lawson; Andrew Gross
Journal:  N Engl J Med       Date:  2004-03-25       Impact factor: 91.245

2.  Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo.

Authors:  Lauri L Laichalk; David A Thorley-Lawson
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

3.  Epstein-Barr virus latent membrane protein 2A is a B-cell receptor mimic and essential for B-cell survival.

Authors:  Christoph Mancao; Wolfgang Hammerschmidt
Journal:  Blood       Date:  2007-08-06       Impact factor: 22.113

4.  Tumor necrosis factor-alpha and interleukin-10 promoter polymorphisms in Epstein-Barr virus-associated gastric carcinoma.

Authors:  Ming-Shiang Wu; Shih-Pei Huang; Yu-Ting Chang; Chia-Tung Shun; Ming-Chu Chang; Ming-Tsan Lin; Hsiu-Po Wang; Jaw-Town Lin
Journal:  J Infect Dis       Date:  2001-12-14       Impact factor: 5.226

5.  Polymorphism of the interleukin-10 gene is associated with susceptibility to Epstein-Barr virus infection.

Authors:  M Helminen; N Lahdenpohja; M Hurme
Journal:  J Infect Dis       Date:  1999-08       Impact factor: 5.226

Review 6.  Epstein-Barr virus and oncogenesis: from latent genes to tumours.

Authors:  Lawrence S Young; Paul G Murray
Journal:  Oncogene       Date:  2003-08-11       Impact factor: 9.867

7.  Polymorphism of the IL-1 gene complex in Epstein-Barr virus seronegative and seropositive adult blood donors.

Authors:  M Hurme; M Helminen
Journal:  Scand J Immunol       Date:  1998-09       Impact factor: 3.487

8.  HLA class I polymorphisms are associated with development of infectious mononucleosis upon primary EBV infection.

Authors:  Karen A McAulay; Craig D Higgins; Karen F Macsween; Annette Lake; Ruth F Jarrett; Faye L Robertson; Hilary Williams; Dorothy H Crawford
Journal:  J Clin Invest       Date:  2007-10       Impact factor: 14.808

9.  HLA-A*02 is associated with a reduced risk and HLA-A*01 with an increased risk of developing EBV+ Hodgkin lymphoma.

Authors:  Marijke Niens; Ruth F Jarrett; Bouke Hepkema; Ilja M Nolte; Arjan Diepstra; Mathieu Platteel; Niels Kouprie; Craig P Delury; Alice Gallagher; Lydia Visser; Sibrand Poppema; Gerard J te Meerman; Anke van den Berg
Journal:  Blood       Date:  2007-07-13       Impact factor: 22.113

10.  Characteristics of Hodgkin's lymphoma after infectious mononucleosis.

Authors:  Henrik Hjalgrim; Johan Askling; Klaus Rostgaard; Stephen Hamilton-Dutoit; Morten Frisch; Jin-Song Zhang; Mette Madsen; Nils Rosdahl; Helle Bossen Konradsen; Hans H Storm; Mads Melbye
Journal:  N Engl J Med       Date:  2003-10-02       Impact factor: 91.245

View more
  3 in total

1.  Evidence of genetic susceptibility to infectious mononucleosis: a twin study.

Authors:  A E Hwang; A S Hamilton; M G Cockburn; R Ambinder; J Zadnick; E E Brown; T M Mack; W Cozen
Journal:  Epidemiol Infect       Date:  2011-12-08       Impact factor: 2.451

2.  The Epstein-Barr Virus Lytic Protein BZLF1 as a Candidate Target Antigen for Vaccine Development.

Authors:  Alex S Hartlage; Tom Liu; John T Patton; Sabrina L Garman; Xiaoli Zhang; Habibe Kurt; Gerard Lozanski; Mark E Lustberg; Michael A Caligiuri; Robert A Baiocchi
Journal:  Cancer Immunol Res       Date:  2015-03-03       Impact factor: 11.151

3.  The causal cascade to multiple sclerosis: a model for MS pathogenesis.

Authors:  Douglas S Goodin
Journal:  PLoS One       Date:  2009-02-26       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.